Literature DB >> 8234176

Phosphoryloxymethyl carbamates and carbonates--novel water-soluble prodrugs for amines and hindered alcohols.

M Safadi1, R Oliyai, V J Stella.   

Abstract

Phosphoryloxymethyl carbonates and carbamates of the type R1R2X-CO-O-CH2-O-PO3(-2) (X = O or N) were evaluated as potentially novel water-soluble collapsible prodrugs for alcohols and amines. These were prepared by reaction of alpha-chloromethyl chloroformate with the starting alcohol or amine to give the corresponding alpha-chloromethyl carbonate or carbamate, respectively. Reaction with silver dibenzyl phosphate followed by debenzylation by hydrogenolysis gave the desired products. The aqueous chemical stability of the phosphoryloxymethylcarbonyl derivatives of 2-indanol (3a), beta-(3,4-dimethoxyphenyl)ethylamine (3b), and benzocaine (3c) were evaluated. The aqueous hydrolysis of 3a-3c resulted in regeneration of the parent alcohol or amines. As expected, the hydrolytic behaviors of these derivatives were found to differ from that of simple alkyl and aryl phosphomonoesters. The rates of hydrolysis were extremely rapid, with the dianionic phosphate species possessing a higher reactivity than the monoanionic species. This was attributed to the proximity of the phosphate group to the carbonyl moiety. The carbamate derivatives, 3b and 3c, displayed greater chemical stability compared to the carbonate derivative, 3a. Alkaline phosphatases-mediated hydrolysis of the phosphate ester bond in 3c led to a rapid cascade reaction resulting in regeneration of the parent amine, benzocaine. Although the alcohol derivative described here appeared to be too chemically unstable to be ideal as a prodrug, the derivatives of the amines might have some use. They are expected to be cleaved in vivo by alkaline phosphatases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234176     DOI: 10.1023/a:1018934200343

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Effects of structural variations on the rates of enzymatic and nonenzymatic hydrolysis of carbonate and carbamate esters.

Authors:  M N Nassar; B J Agha; G A Digenis
Journal:  J Pharm Sci       Date:  1992-03       Impact factor: 3.534

2.  Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate.

Authors:  K I Plaisance; G L Drusano; A Forrest; R J Townsend; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  Bioavailability of dexamethasone. II. Dexamethasone phosphate.

Authors:  L E Hare; K C Yeh; C A Ditzler; F G McMahon; D E Duggan
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

4.  Pharmacokinetics and dose linearity testing of methylprednisolone phosphate.

Authors:  H Möllmann; P Rohdewald; J Barth; M Verho; H Derendorf
Journal:  Biopharm Drug Dispos       Date:  1989 Sep-Oct       Impact factor: 1.627

5.  Pharmacokinetics of triamcinolone acetonide and its phosphate ester.

Authors:  H Möllmann; P Rohdewald; E W Schmidt; V Salomon; H Derendorf
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: a new prodrug of phenytoin.

Authors:  N Gerber; D C Mays; K H Donn; A Laddu; R M Guthrie; P Turlapaty; C Y Quon; W K Rivenburg
Journal:  J Clin Pharmacol       Date:  1988-11       Impact factor: 3.126

7.  Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.

Authors:  P O Gunnarsson; S B Andersson; S A Johansson; T Nilsson; G Plym-Forshell
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Phenytoin prodrugs IV: Hydrolysis of various 3-(hydroxymethyl)phenytoin esters.

Authors:  S A Varia; S Schuller; V J Stella
Journal:  J Pharm Sci       Date:  1984-08       Impact factor: 3.534

9.  The in vitro enzymic labilities of chemically distinct phosphomonoester prodrugs.

Authors:  A S Kearney; V J Stella
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

10.  (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.

Authors:  J Alexander; R Cargill; S R Michelson; H Schwam
Journal:  J Med Chem       Date:  1988-02       Impact factor: 7.446

  10 in total
  10 in total

1.  Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution.

Authors:  L C Yuan; T C Dahl; R Oliyai
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

2.  Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionality.

Authors:  Kristiina M Huttunen; Niina Mähönen; Jukka Leppänen; Jouko Vepsäläinen; Risto O Juvonen; Hannu Raunio; Hanna Kumpulainen; Tomi Järvinen; Jarkko Rautio
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

3.  Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Mohamed O Hamad; Jianhong Chen; Stan L Banks; Peter A Crooks; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

4.  Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.

Authors:  J P Shaw; C M Sueoko; R Oliyai; W A Lee; M N Arimilli; C U Kim; K C Cundy
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

5.  A mechanistic and kinetic study of the E-ring hydrolysis and lactonization of a novel phosphoryloxymethyl prodrug of camptothecin.

Authors:  Bradley A Hanson; Richard L Schowen; Valentino J Stella
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

6.  Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Stan L Banks; Jianhong Chen; Dana C Hammell; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

7.  Synthesis of a highly water-soluble acacetin prodrug for treating experimental atrial fibrillation in beagle dogs.

Authors:  Hui Liu; Ya-Jing Wang; Lei Yang; Mei Zhou; Man-Wen Jin; Guo-Sheng Xiao; Yan Wang; Hai-Ying Sun; Gui-Rong Li
Journal:  Sci Rep       Date:  2016-05-10       Impact factor: 4.379

8.  Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts.

Authors:  Satish Patil; Lev G Lis; Robert J Schumacher; Beverly J Norris; Monique L Morgan; Rebecca A D Cuellar; Bruce R Blazar; Raj Suryanarayanan; Vadim J Gurvich; Gunda I Georg
Journal:  J Med Chem       Date:  2015-11-24       Impact factor: 7.446

Review 9.  Prodrugs for amines.

Authors:  Ana L Simplício; John M Clancy; John F Gilmer
Journal:  Molecules       Date:  2008-03-03       Impact factor: 4.411

Review 10.  Development and Clinical Application of Phosphorus-Containing Drugs.

Authors:  Hanxiao Yu; He Yang; Enxue Shi; Wenjun Tang
Journal:  Med Drug Discov       Date:  2020-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.